![N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-B]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide](https://static.cymitquimica.com/cas-image/395357-n-2-3-1-piperazinylmethyl-imidazo-21-b-thiazol-6-yl-phenyl-2-quinoxalinecarboxamide.png)
CAS: 925434-55-5 - N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-B]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide
Formula:C25H23N7OS
InChI:InChI=1S/C25H23N7OS/c33-24(22-13-27-20-7-3-4-8-21(20)28-22)29-19-6-2-1-5-18(19)23-15-32-17(16-34-25(32)30-23)14-31-11-9-26-10-12-31/h1-8,13,15-16,26H,9-12,14H2,(H,29,33)
InChI key:InChIKey=IASPBORHOMBZMY-UHFFFAOYSA-N
SMILES:O=C(NC=1C=CC=CC1C=2N=C3SC=C(N3C2)CN4CCNCC4)C5=NC6=CC=CC=C6N=C5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SRT 1720 REF: AN-AG0064FXCAS: 925434-55-5 | 98% | To inquire | Thu 30 May 24 |
 | SRT 1720 REF: TM-T5096CAS: 925434-55-5 | 99.7% | 39.00 €~423.00 € | Fri 07 Jun 24 |
 | SRT 1720 REF: 3D-FP41292CAS: 925434-55-5 | Min. 95% | To inquire | Thu 11 Jul 24 |
Ref: AN-AG0064FX
| 1mg | 133.00 € | |
| 2mg | 198.00 € | |
| 5mg | 204.00 € | |
| 10mg | 300.00 € | |
| 25mg | 547.00 € | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 30 May 2024
SRT 1720
CAS:925434-55-5
SRT 1720 is a selective activator of human SIRT1 (EC1.5: 0.16 μM) and is >230-fold …
Formula:
C25H23N7OS
Purity:
99.7%
Color and Shape:
Solid
Molecular weight:
469.56
- Inhibitors
- Chromatin/Epigenetics
- DNA Damage/DNA Repair
- Sirtuin
- See more categories
- Autophagy
Ref: TM-T5096
| 2mg | 39.00 € | |
| 5mg | 57.00 € | |
| 10mg | 78.00 € | |
| 25mg | 149.00 € | |
| 50mg | 254.00 € | |
| 100mg | 423.00 € | |
| 1ml*10 (DMSO) | 89.00 € |
Estimated delivery in United States, on Friday 7 Jun 2024
SRT 1720
CAS:925434-55-5
SIRT1 activator
Formula:
C25H23N7OS
Purity:
Min. 95%
Molecular weight:
469.56 g/mol
Ref: 3D-FP41292
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Thursday 11 Jul 2024
